About Kardium
Kardium is a company based in Vancouver (Canada) founded in 2007 by Sam Lichtenstein, Dan Gelbart, and Doug Goertzen. Kardium has raised $471.44 million across 6 funding rounds from investors including Fidelity Investments, T. Rowe Price and Janus Henderson Investors. Kardium offers products and services including Globe Pulsed Field System. Kardium operates in a competitive market with competitors including Argá Medtech, Adagio Medical, Farapulse, Affera and Field Medical, among others.
- Headquarter Vancouver, Canada
- Founders Sam Lichtenstein, Dan Gelbart, Doug Goertzen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kardium Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$471.44 M (USD)
in 6 rounds
-
Latest Funding Round
$250 M (USD), Series C
Jul 08, 2025
-
Investors
Fidelity Investments
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kardium
Kardium offers a comprehensive portfolio of products and services, including Globe Pulsed Field System.
Catheter for atrial fibrillation ablation and mapping in real-time.
People of Kardium
Unlock access to complete
Unlock access to complete
Funding Insights of Kardium
Kardium has successfully raised a total of $471.44M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $250 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kardium
Kardium has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Janus Henderson Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are offered by Durable Capital Partners.
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Eventide is engaged in values-based investment management services.
|
Locked | Locked | Locked |
Investor details for Kardium
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kardium
Investment portfolio details for Kardium
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kardium
Detailed financials for Kardium
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kardium Comparisons
Peer comparison for Kardium
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kardium
Kardium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Argá Medtech, Adagio Medical, Farapulse, Affera and Field Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for cardiac arrhythmias are developed by Argá Medtech.
|
|
| Locked | Locked | Locked |
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
|
|
| Locked | Locked | Locked |
Devices for cardiac ablation via pulsed field technology are developed.
|
|
| Locked | Locked | Locked |
Devices for treating heart rhythm disorders are developed.
|
|
| Locked | Locked | Locked |
Pulsed electric field ablation devices for heart arrhythmias are developed.
|
Detailed competitors of Kardium
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kardium
Complete news archive for Kardium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kardium
Kardium was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Kardium is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Kardium is a funded company, having raised a total of $471.44M across 6 funding rounds to date.
Kardium was founded in 2007 in Vancouver, Canada, within the medical device sector. Focus is placed on the Globe mapping and ablation system, an investigational tool for diagnosing and treating atrial fibrillation. Cardiac tissue mapping, stimulation, and radiofrequency ablation are enabled by the device. Operations center on advancing cardiac electrophysiology solutions for clinical use.
Kardium's top competitors include Adagio Medical, Field Medical and Argá Medtech.
Kardium offers Globe Pulsed Field System.
Kardium has 8 investors. Key investors include Fidelity Investments, T. Rowe Price, Janus Henderson Investors, Piper Sandler, and Durable Capital Partners.